Sanofi, Zealand hit by U.S. setback for diabetes drug

September 12, 2013 5:17 AM

10 0

Sanofi, Zealand hit by U.S. setback for diabetes drug

PARIS (Reuters) - French drugmaker Sanofi said on Thursday it would withdraw its U.S. application for diabetes treatment lixisenatide in order to wait for results from an ongoing cardiovascular patient study.

The decision, which will delay the drug's launch in the world's biggest market, sent shares in Sanofi down 1.6 percent by 0720 GMT, while its smaller Danish partner Zealand Pharma dropped 20 percent.

Read more

To category page

Loading...